Cite

Since the introduction of prophylaxis as a treatment for haemophilia, treatment goals have aimed at moving people with haemophilia (PwH) out of a ‘danger zone’ and into an experience of stability around their condition. As even more effective treatments become available, it may be time to move beyond this focus on treating for stability, toward more ambitious outcomes and possibilities for PwH.
Since the introduction of prophylaxis as a treatment for haemophilia, treatment goals have aimed at moving people with haemophilia (PwH) out of a ‘danger zone’ and into an experience of stability around their condition. As even more effective treatments become available, it may be time to move beyond this focus on treating for stability, toward more ambitious outcomes and possibilities for PwH.

Comparison of treatment regimen and outcomes reported by Irish and non-Irish participants

IRISH RESPONDENTSNON-IRISH RESPONDENTS
PwH on prophylaxis treatment and fully adherent12 out of 12100%28 out of 3975%
PwH who adapt their treatment regimen to physical activities8 out of 1266.6%12 out of 3930.8%
Non-inhibitor PwH who had a bleed in the last year*3 out of 1030%23 out of 3369.7%
PwH (or carers) who are generally adherent to prophylaxis treatment who worry about not being adequately protected**3 out of 1225%14 out of 3342.4%
eISSN:
2055-3390
Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Basic Medical Science, other, Clinical Medicine, Pharmacy, Pharmacology